We would like to update you with a recent brochure from Thermo Fisher Scientific on the ImmunoCAPTM ECP for quantifying eosinophil cationic protein (ECP).
ImmunoCAP ECP measures the level of eosinophil cationic protein (ECP) in serum. A high level of serum ECP indicates inflammation, which is a risk factor for asthmatic patients. Measuring ECP in a serum sample is an objective and direct way of estimating the severity of airway inflammation and following the course of disease in asthmatic patients.
The clinical importance of ImmunoCAP ECP serum measurements in asthma is to monitor inflammation in asthma, to guide corticosteroid treatment in asthma and to find non-compliant patients.